Variant report
Variant | esv2520194 |
---|---|
Chromosome Location | chr2:213529709-213531182 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144544535 | chr2:213529716-213529717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148337950 | chr2:213529720-213529721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142020713 | chr2:213529760-213529761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551033990 | chr2:213529795-213529796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569352623 | chr2:213529800-213529801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185909252 | chr2:213529895-213529896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11896992 | chr2:213529898-213529899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs146313728 | chr2:213530015-213530016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555823832 | chr2:213530051-213530052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2371710 | chr2:213530069-213530070 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs201437000 | chr2:213530145-213530146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555602697 | chr2:213530146-213530147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567661747 | chr2:213530172-213530173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188156123 | chr2:213530178-213530179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556564610 | chr2:213530183-213530184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575232111 | chr2:213530224-213530225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545847081 | chr2:213530284-213530285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367656567 | chr2:213530333-213530334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200084579 | chr2:213530400-213530401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557588507 | chr2:213530476-213530477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572945386 | chr2:213530498-213530499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540436700 | chr2:213530540-213530541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376630232 | chr2:213530554-213530555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529233347 | chr2:213530614-213530615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541621160 | chr2:213530647-213530648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139478860 | chr2:213530651-213530652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181092242 | chr2:213530655-213530656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185532188 | chr2:213530692-213530693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13423818 | chr2:213530778-213530779 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs566863283 | chr2:213530787-213530788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527879532 | chr2:213530866-213530867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549214313 | chr2:213530928-213530929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112097684 | chr2:213530929-213530930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs66813265 | chr2:213530930-213530931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs386392509 | chr2:213530932-213530933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10644779 | chr2:213530934-213530935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572261284 | chr2:213530944-213530945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190235644 | chr2:213530978-213530979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530727722 | chr2:213530998-213530999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540968601 | chr2:213531004-213531005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10168708 | chr2:213531019-213531020 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs568805706 | chr2:213531060-213531061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539065391 | chr2:213531087-213531088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13424220 | chr2:213531099-213531100 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs572892740 | chr2:213531101-213531102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13424239 | chr2:213531142-213531143 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs559260247 | chr2:213531144-213531145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144532859 | chr2:213531177-213531178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:213529600-213532800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr2:213530000-213531400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr2:213531000-213531200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr2:213531000-213532600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |